These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24253427)

  • 1. The role of neutrophils in cystic fibrosis.
    Gifford AM; Chalmers JD
    Curr Opin Hematol; 2014 Jan; 21(1):16-22. PubMed ID: 24253427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophilic inflammation as a major determinant in the progression of cystic fibrosis.
    Tirouvanziam R
    Drug News Perspect; 2006 Dec; 19(10):609-14. PubMed ID: 17299603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of airway inflammation in cystic fibrosis.
    Konstan MW
    Curr Opin Pulm Med; 1996 Nov; 2(6):452-6. PubMed ID: 9363184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum.
    Dubois AV; Gauthier A; Bréa D; Varaigne F; Diot P; Gauthier F; Attucci S
    Am J Respir Cell Mol Biol; 2012 Jul; 47(1):80-6. PubMed ID: 22343221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cystic fibrosis neutrophil: a specialized yet potentially defective cell.
    Hayes E; Pohl K; McElvaney NG; Reeves EP
    Arch Immunol Ther Exp (Warsz); 2011 Apr; 59(2):97-112. PubMed ID: 21311988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease.
    Conese M; Copreni E; Di Gioia S; De Rinaldis P; Fumarulo R
    J Cyst Fibros; 2003 Sep; 2(3):129-35. PubMed ID: 15463861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications.
    Cohen-Cymberknoh M; Kerem E; Ferkol T; Elizur A
    Thorax; 2013 Dec; 68(12):1157-62. PubMed ID: 23704228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy.
    Cantin AM; Hartl D; Konstan MW; Chmiel JF
    J Cyst Fibros; 2015 Jul; 14(4):419-30. PubMed ID: 25814049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
    Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
    Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretory leukocyte protease inhibitor in cystic fibrosis.
    Stromatt SC
    Agents Actions Suppl; 1993; 42():103-10. PubMed ID: 8102834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The design of novel classes of macrolides for neutrophil-dominated inflammatory diseases.
    Eraković Haber V; Bosnar M; Kragol G
    Future Med Chem; 2014 Apr; 6(6):657-74. PubMed ID: 24895894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
    Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cystic fibrosis exacerbations on neutrophil function.
    Brockbank S; Downey D; Elborn JS; Ennis M
    Int Immunopharmacol; 2005 Mar; 5(3):601-8. PubMed ID: 15683855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil elastase inhibitors: recent advances in the development of mechanism-based and nonelectrophilic inhibitors.
    Sjö P
    Future Med Chem; 2012 Apr; 4(5):651-60. PubMed ID: 22458683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
    McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
    J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
    Nakamura H; Yoshimura K; McElvaney NG; Crystal RG
    J Clin Invest; 1992 May; 89(5):1478-84. PubMed ID: 1569186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
    Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
    Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory effects of DX-890, a human neutrophil elastase inhibitor.
    Dunlevy FK; Martin SL; de Courcey F; Elborn JS; Ennis M
    J Cyst Fibros; 2012 Jul; 11(4):300-4. PubMed ID: 22418019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory approaches to the treatment of cystic fibrosis lung disease: past, present and future.
    Oermann CM
    Curr Opin Investig Drugs; 2001 Jul; 2(7):900-6. PubMed ID: 11757788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
    Witko-Sarsat V; Sermet-Gaudelus I; Lenoir G; Descamps-Latscha B
    Mediators Inflamm; 1999; 8(1):7-11. PubMed ID: 10704083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.